Výsledky vyhledávání - Martin H. Voss

Upřesnit hledání
  1. 1
    mTOR Inhibitors in Advanced Renal Cell Carcinoma

    mTOR Inhibitors in Advanced Renal Cell Carcinoma Autor Martin H. Voss, Ana M. Molina, Robert J. Motzer

    Vydáno 2011
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma

    Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma Autor Maria I. Carlo, Martin H. Voss, Robert J. Motzer

    Vydáno 2016
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma

    Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma Autor Kyrollis Attalla, Stanley Weng, Martin H. Voss, A. Ari Hakimi

    Vydáno 2020
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma

    Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma Autor Lynda Vuong, Ritesh R. Kotecha, Martin H. Voss, A. Ari Hakimi

    Vydáno 2019
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events Autor Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell Lymphoma: A Single Institution Experience

    Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell... Autor Martin H. Voss, Matthew A. Lunning, Jocelyn Maragulia, Esperanza B. Papadopoulos, Jeffrey L. Goldberg, Andrew D. Zelenetz, Steven M. Horwitz

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma

    Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma Autor Martin H. Voss, David Chen, Mahtab Marker, A. Ari Hakimi, Chung‐Han Lee, James J. Hsieh, Jennifer J. Knox, Maurizio Voi, Robert J. Motzer

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma

    Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma Autor Ana M. Molina, Darren R. Feldman, Martin H. Voss, Michelle S. Ginsberg, Michael Baum, Dion R. Brocks, Patricia M. Fischer, M. J. Trinos, Sujata Patil, Robert J. Motzer

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies

    Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies Autor Martin H. Voss, Diogo Assed Bastos, Christoph Karlo, Albulena Ajeti, A. Ari Hakimi, Darren R. Feldman, Jia‐Juan Hsieh, Ana M. Molina, Sujata Patil, Robert J. Motzer

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study

    Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study Autor Martin H. Voss, Albert Reising, Yuan Cheng, Parul Patel, Mahtab Marker, Fengshen Kuo, Timothy A. Chan, Toni K. Choueiri, James J. Hsieh, A. Ari Hakimi, Robert J. Motzer

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma

    A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma Autor Maria I. Carlo, Ana M. Molina, Yulia Lakhman, Sujata Patil, Kaitlin M. Woo, John DeLuca, Chung‐Han Lee, James J. Hsieh, Darren R. Feldman, Robert J. Motzer, Martin H. Voss

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups

    Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups Autor Guillermo de Velasco, Diana Miao, Martin H. Voss, A. Ari Hakimi, James J. Hsieh, Nizar M. Tannir, Pheroze Tamboli, Leonard J. Appleman, W. Kimryn Rathmell, Eliezer M. Van Allen, Toni K. Choueiri

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes

    Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes Autor Yasser Ged, Ying‐Bei Chen, Andrea Knežević, Mark T.A. Donoghue, Maria I. Carlo, Chung‐Han Lee, Darren R. Feldman, Sujata Patil, A. Ari Hakimi, Paul Russo, Martin H. Voss, Robert J. Motzer

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)–tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma

    Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)–tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with me... Autor Rosa Nadal, A. Amin, Daniel M. Geynisman, Martin H. Voss, Matthew Weinstock, Jaime Doyle, Zhi Zhang, A. Viúdez, Elizabeth R. Plimack, David F. McDermott, Robert J. Motzer, Brian I. Rini, Hans J. Hammers

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade

    Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade Autor Jason Beattie, Hira Rizvi, Paige Fuentes, Jia Luo, Adam J. Schoenfeld, I‐Hsin Lin, Michael A. Postow, Margaret K. Callahan, Martin H. Voss, Neil J. Shah, Allison Betof Warner, Mohit Chawla, Matthew D. Hellmann

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer

    Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer Autor Ying‐Bei Chen, A. Rose Brannon, Antoun Toubaji, Mária Dudás, Helen Won, Hikmat Al‐Ahmadie, Samson W. Fine, Anuradha Gopalan, Norma Frizzell, Martin H. Voss, Paul Russo, Michael F. Berger, Satish K. Tickoo, Victor E. Reuter

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes

    Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes Autor Yasser Ged, Ying‐Bei Chen, Andrea Knežević, Jozefina Casuscelli, Almedina Redzematovic, Renzo G. DiNatale, Maria I. Carlo, Chung‐Han Lee, Darren R. Feldman, Sujata Patil, A. Ari Hakimi, Paul Russo, Robert J. Motzer, Martin H. Voss

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

    A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer Autor James J. Harding, Andrew X. Zhu, Todd M. Bauer, Toni K. Choueiri, Alexander Drilon, Martin H. Voss, Charles S. Fuchs, Ghassan K. Abou‐Alfa, Sameera R. Wijayawardana, Xuejing Aimee Wang, Brian A. Moser, Arantxa Uruñuela, Volker Wacheck, Johanna C. Bendell

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma

    Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma Autor A. Ari Hakimi, Ying‐Bei Chen, James Wren, Mithat Gönen, Omar Abdel‐Wahab, Adriana Heguy, Han Liu, Shugaku Takeda, Satish K. Tickoo, Victor E. Reuter, Martin H. Voss, Robert J. Motzer, Jonathan Coleman, Emily H. Cheng, Paul Russo, James J. Hsieh

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators <i>BAP1</i> and <i>SETD2</i>: A Report by MSKCC and the KIRC TCGA Research Network

    Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators <i>BAP1</i> and <i>SETD2</i>: A Report by MSKCC and the KIRC TCGA Research Network Autor A. Ari Hakimi, Irina Ostrovnaya, Boris Reva, Nikolaus Schultz, Ying‐Bei Chen, Mithat Gönen, Han Liu, Shugaku Takeda, Martin H. Voss, Satish K. Tickoo, Victor E. Reuter, Paul Russo, Emily H. Cheng, Chris Sander, Robert J. Motzer, James J. Hsieh

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: